Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

Pharmaceutical Manufacturing

San Diego, California 6,808 followers

About us

Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and endocrine disorders. Our most advanced candidate is a non-steroidal selective androgen receptor modulator (SARM) currently in Phase 2 trial for the treatment recovery from hip fracture surgery. Our thyroid receptor beta (TRb) agonist platform, also in Phase 2, is being developed for lipid disorders such as hypercholesterolemia and fatty liver diseases such as non-alcoholic steatohepatitis (NASH) as well as for rare diseases of glycogen storage disease (GSD 1a) and X-linked adrenoleukodystrophy, or X-ALD. See more at http://www.vikingtherapeutics.com

Website
http://vikingtherapeutics.com
Industry
Pharmaceutical Manufacturing
Company size
11-50 employees
Headquarters
San Diego, California
Type
Public Company
Founded
2012

Locations

Employees at Viking Therapeutics, Inc.

Similar pages

Browse jobs

Funding

Viking Therapeutics, Inc. 7 total rounds

Last Round

Post IPO equity

US$ 632.5M

See more info on crunchbase